Bdron™ is a quality assured generic of Zytiga® which is approved to treat prostate cancer. It is used in combination with prednisone for the treatment of metastatic castration resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adult men.
top of page
$355.00 Regular Price
$248.50Sale Price
No Reviews YetShare your thoughts.
Be the first to leave a review.
You Might Also Like
bottom of page

















